Clinical trial
A Multicenter Phase 2, Single-Arm Open-Label Study of DCC-2618 to Assess Efficacy, Safety, and Pharmacokinetics In Patients With Advanced Gastrointestinal Stromal Tumors Who Have Progressed On Prior Anticancer Therapies.
NCT04282980 is registered in ClinicalTrials.gov with Zai Lab (Shanghai) Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter Phase 2, Single-Arm Open-Label Study of DCC-2618 to Assess Efficacy, Safety, and Pharmacokinetics In Patients With Advanced Gastrointestinal Stromal Tumors Who Have Progressed On Prior Anticancer Therapies.
- Lead sponsor
- Zai Lab (Shanghai) Co., Ltd.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- April 23, 2020
- Completion date
- August 23, 2022
- Enrollment
- 39 (actual)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.